
In the randomized trial of 60 patients with symptomatic oral lichen planus, combined therapy (TA+HA) and monotherapies (TA or HA) significantly improved clinical scores (Thongprasom, VAS, OHIP-14) over 28 days, with effects sustained at 3-month follow-up (p < 0.001). However, no significant changes in salivary oxidative stress markers (SOD, GSH, TAC) were observed in any treatment group.
Like
Save
Share